Search research articles
Contact Us
Filters
Showing results (11-20 of 23) with videos related to
Page
of 3
Sort By:
ACS Chemical Biology
|
September 17, 2019
Rapid Identification of Novel Allosteric PRC2 Inhibitors
Jon A Read, Jonathan Tart, Philip B Rawlins, et al.
SLAS Discovery : Advancing Life Sciences R & D
|
October 30, 2016
Unified Software Solution for Efficient SPR Data Analysis in Drug Research
Göran Dahl, Stephan Steigele, Per Hillertz, et al.
Archives of Toxicology
|
January 1, 2022
Pharmacological inhibition of MERTK induces in vivo retinal degeneration: a multimodal imaging ocular safety assessment
Gregory Hamm, Gareth Maglennon, Beth Williamson, et al.
RSC Medicinal Chemistry
|
November 3, 2022
Fragment screening at AstraZeneca: developing the next generation biophysics fragment set
Simon C C Lucas, Ulf Börjesson, Mark J Bostock, et al.
ACS Medicinal Chemistry Letters
|
June 18, 2025
Discovery of Pyrimidoindolones as Novel Family VIII Bromodomain Binders
Jeffrey A Boerth, Marianne Schimpl, Simon C C Lucas, et al.
Bioorganic & Medicinal Chemistry Letters
|
March 8, 2021
Free energy perturbation in the design of EED ligands as inhibitors of polycomb repressive complex 2 (PRC2) methyltransferase
Daniel H O' Donovan, Clare Gregson, Martin J Packer, et al.
Journal of Medicinal Chemistry
|
March 8, 2021
Generating Selective Leads for Mer Kinase Inhibitors-Example of a Comprehensive Lead-Generation Strategy
J Willem M Nissink, Sana Bazzaz, Carolyn Blackett, et al.
Journal of Medicinal Chemistry
|
May 10, 2017
Discovery of Pyrazolo[1,5-a]pyrimidine B-Cell Lymphoma 6 (BCL6) Binders and Optimization to High Affinity Macrocyclic Inhibitors
William McCoull, Roman D Abrams, Erica Anderson, et al.
ACS Chemical Biology
|
October 19, 2018
Development of a Novel B-Cell Lymphoma 6 (BCL6) PROTAC To Provide Insight into Small Molecule Targeting of BCL6
William McCoull, Tony Cheung, Erica Anderson, et al.
ACS Medicinal Chemistry Letters
|
November 21, 2017
Correction to "Structure Based Design of Non-Natural Peptidic Macrocyclic Mcl-1 Inhibitors"
Jeffrey W Johannes, Stephanie Bates, Carl Beigie, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 23) with videos related to
Sort By:
Page
of 3
ACS Chemical Biology
|
September 17, 2019
Rapid Identification of Novel Allosteric PRC2 Inhibitors
Jon A Read, Jonathan Tart, Philip B Rawlins, et al.
SLAS Discovery : Advancing Life Sciences R & D
|
October 30, 2016
Unified Software Solution for Efficient SPR Data Analysis in Drug Research
Göran Dahl, Stephan Steigele, Per Hillertz, et al.
Archives of Toxicology
|
January 1, 2022
Pharmacological inhibition of MERTK induces in vivo retinal degeneration: a multimodal imaging ocular safety assessment
Gregory Hamm, Gareth Maglennon, Beth Williamson, et al.
RSC Medicinal Chemistry
|
November 3, 2022
Fragment screening at AstraZeneca: developing the next generation biophysics fragment set
Simon C C Lucas, Ulf Börjesson, Mark J Bostock, et al.
ACS Medicinal Chemistry Letters
|
June 18, 2025
Discovery of Pyrimidoindolones as Novel Family VIII Bromodomain Binders
Jeffrey A Boerth, Marianne Schimpl, Simon C C Lucas, et al.
Bioorganic & Medicinal Chemistry Letters
|
March 8, 2021
Free energy perturbation in the design of EED ligands as inhibitors of polycomb repressive complex 2 (PRC2) methyltransferase
Daniel H O' Donovan, Clare Gregson, Martin J Packer, et al.
Journal of Medicinal Chemistry
|
March 8, 2021
Generating Selective Leads for Mer Kinase Inhibitors-Example of a Comprehensive Lead-Generation Strategy
J Willem M Nissink, Sana Bazzaz, Carolyn Blackett, et al.
Journal of Medicinal Chemistry
|
May 10, 2017
Discovery of Pyrazolo[1,5-a]pyrimidine B-Cell Lymphoma 6 (BCL6) Binders and Optimization to High Affinity Macrocyclic Inhibitors
William McCoull, Roman D Abrams, Erica Anderson, et al.
ACS Chemical Biology
|
October 19, 2018
Development of a Novel B-Cell Lymphoma 6 (BCL6) PROTAC To Provide Insight into Small Molecule Targeting of BCL6
William McCoull, Tony Cheung, Erica Anderson, et al.
ACS Medicinal Chemistry Letters
|
November 21, 2017
Correction to "Structure Based Design of Non-Natural Peptidic Macrocyclic Mcl-1 Inhibitors"
Jeffrey W Johannes, Stephanie Bates, Carl Beigie, et al.
Page
of 3